Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Matthew Geller currently holds 5,000 shares of BIOSPECIFICS TECHNOLOGIES CORP (BSTC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew Geller has been a net seller of BSTC stock. They have purchased $0 and sold $724.8K worth of shares.
Matthew Geller's most recent insider trade was on Jun 7, 2011, when they sold 5,000 shares at $24.57 per share.
Matthew Geller serves as Executive at BIOSPECIFICS TECHNOLOGIES CORP (BSTC). They have executed 8 insider transactions totaling $724.8K over their tenure at the company.
Matthew Geller holds the position of Executive at BIOSPECIFICS TECHNOLOGIES CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
Matthew Geller has shown a selling trading pattern, with $0 in total purchases and $724.8K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Matthew Geller was on Apr 15, 2010, when they sold $285.0K worth of BSTC shares. This transaction involved 15,000 shares at $19.00 per share.
Matthew Geller currently owns 5,000 shares of BIOSPECIFICS TECHNOLOGIES CORP (BSTC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Matthew Geller's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Matthew Geller has 8 Form 4 filings on record as an insider at BIOSPECIFICS TECHNOLOGIES CORP.
Set alerts for Matthew Geller and 40,000+ other insiders.